Bioprosthetic Valve Thrombosis while on a Novel Oral Anticoagulant for Atrial Fibrillation

服用新型口服抗凝剂治疗房颤期间发生生物瓣膜血栓形成

阅读:1

Abstract

• BPVT occurred while on a DOAC for treatment of AF. • Echocardiographic and pathologic images of BPVT are shown. • The definition of NVAF is not uniform in clinical trials or guidelines. • The optimal anticoagulation strategy for BPV and AF is unclear. • Caution is advised in using DOACs for AF in patients with BPVs.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。